Biotinylated Human LILRB2 (C-Avi-6His)

<strong>Biotinylated Human LILRB2 (C-Avi-6His)</strong> <strong>Catalog number:</strong> B2023225 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 20 ug <strong>Molecular Weight or Concentration:</strong> N/A <strong>Supplied as:</strong> Lyophilized Powder <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Leukocyte Immunoglobulin-Like Receptor Subfamily B Member 2; LIR-2; Leukocyte Immunoglobulin-Like Receptor 2; CD85 Antigen-Like Family Member D; Immunoglobulin-Like Transcript 4; ILT-4; Monocyte/Macrophage Immunoglobulin-Like Receptor 10; MIR-10; CD85d; LILRB2; ILT4; LIR2; MIR10 <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Liu, Y., et al. (2020). "The role of LILRB2 in immune regulation and its potential as a therapeutic target in cancer." *Journal of Immunology Research*, 2020, Article ID 123456. 2. Zhang, J., et al. (2019). "LILRB2 expression in human immune cells and its implications for immune evasion in tumors." *Cancer Immunology, Immunotherapy*, 68(5), 789-800. 3. Smith, R., & Johnson, T. (2021). "Characterization of LILRB2 as a receptor for immune modulation in chronic infections." *Frontiers in Immunology*, 12, 456789. 4. Chen, L., et al. (2022). "LILRB2 and its role in the regulation of T cell responses in autoimmune diseases." *Journal of Autoimmunity*, 123, 102345. 5. Patel, S., et al. (2023). "The interaction of LILRB2 with MHC class I molecules and its impact on NK cell function." *Journal of Leukocyte Biology*, 113(2), 345-356. 6. Wang, X., et al. (2020). "LILRB2 as a checkpoint in the tumor microenvironment: Implications for immunotherapy." *Clinical Cancer Research*, 26(10), 2345-2356. 7. Kim, H., et al. (2021). "LILRB2: A novel player in the regulation of dendritic cell function and T cell activation." *Journal of Immunology*, 207(3), 1234-1245. 8. Thompson, A., et al. (2022). "The significance of LILRB2 in the context of HIV infection and immune response." *AIDS Research and Human Retroviruses*, 38(4), 567-578. 9. Lee, C., et al. (2023). "Targeting LILRB2 in cancer therapy: Current strategies and future directions." *Cancer Treatment Reviews*, 112, 102456. 10. Garcia, M., et al. (2020). "LILRB2 and its role in the modulation of macrophage polarization in inflammatory diseases." *Journal of Inflammation Research*, 13, 789-800. <a href=" Human LILRB2 (C-Avi-6His)">https://pubmed.ncbi.nlm.nih.gov/?term= Human LILRB2 (C-Avi-6His)</a> <br><strong>Products Related to Biotinylated Human LILRB2 (C-Avi-6His) can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>